Calan and Azmacort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calan (verapamil hydrochloride) and Azmacort (triamcinolone acetonide). Common drug interactions include dyspnoea among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Calan and Azmacort. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Calan?

Calan has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,916 Calan users. Check the latest studies of Calan.

What is Azmacort?

Azmacort has active ingredients of triamcinolone acetonide. It is often used in asthma. eHealthMe is studying from 3,612 Azmacort users. Check the latest studies of Azmacort.

On Jul, 11, 2026

21 people who take Calan and Azmacort together, and have interactions are studied.

What are the common drug interactions of Calan and Azmacort, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Difficulty in walking
Hypoaesthesia (reduced sense of touch or sensation)
Renal failure chronic (long lasting kidney dysfunction)
Vomiting
Blood creatine phosphokinase increased
Blood creatinine increased
Blood glucose decreased
Blood potassium decreased
Cardiac disorder

male:

Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Drug effect decreased
Dyspnoea (difficult or laboured respiration)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pneumonia
Productive cough
Pulmonary oedema (fluid accumulation in the lungs)
Renal failure chronic (long lasting kidney dysfunction)

What are the common drug interactions of Calan and Azmacort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Tardive dyskinesia (a disorder that involves involuntary movements)

40-49:

Blood creatinine increased
Proteinuria present
Renal failure chronic (long lasting kidney dysfunction)
Renal impairment (severely reduced kidney function)
Blood creatine phosphokinase increased
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Chest pain
Cough
Drug abuse
Dyspnoea (difficult or laboured respiration)

50-59:

Renal failure chronic (long lasting kidney dysfunction)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Depression
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diarrhoea
Drug effect decreased
Dyspnoea (difficult or laboured respiration)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pneumonia

60+:

Dyspnoea (difficult or laboured respiration)
Difficulty in walking
Oedema peripheral (superficial swelling)
Renal disorder (kidney disease)
Syncope (loss of consciousness with an inability to maintain postural tone)
Tinnitus (a ringing in the ears)
Weakness
Weight increased
White blood cell count increased
Abdominal distension

What are the existing conditions these people have? *

High Blood Cholesterol: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Calan and Azmacort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously